To further verify whether PIP4K2A-mediated tumor impediment is dependent on down-regulation of PI3K/AKT signaling, we conducted in vitro and in vivo rescue experiments (Fig. 4, I–L). The gene discussed is AKT1; the disease is neoplasm.